4//SEC Filing
Ng George K 4
Accession 0001144204-17-048347
CIK 0000850261other
Filed
Sep 14, 8:00 PM ET
Accepted
Sep 15, 9:26 PM ET
Size
8.1 KB
Accession
0001144204-17-048347
Insider Transaction Report
Form 4
Ng George K
See Remarks
Transactions
- Other
Common Stock
2017-09-11+89,339→ 138,677 total
Holdings
- 3,448(indirect: By LLC)
Common Stock
- 11,453(indirect: By Trust)
Common Stock
- 888(indirect: By IRA)
Common Stock
Footnotes (3)
- [F1]Pursuant to a stock purchase agreement by and among the Issuer, Scilex Pharmaceuticals Inc. ("Scilex"), the stockholders of Scilex party thereto and SPI Shareholders Representative, LLC, as representative of the Scilex Stockholders (the "Stock Purchase Agreement"), the Reporting Person sold 1,800,000 shares of common stock of Scilex to the Issuer and, upon the achievement of a milestone on September 11, 2017, the Issuer issued the Reporting Person 89,339 shares of the common stock of the Issuer. The Stock Purchase Agreement, which was entered into on November 8, 2016, placed a value on the Issuer's common stock of $6.33 per share. Contingent upon the achievement of such milestone, the Reporting Person's right to receive such shares became fixed and irrevocable on November 8, 2016.
- [F2]The number of shares reported as indirectly beneficially owned by the Reporting Person through an IRA was inadvertently omitted from prior reports by the Reporting Person.
- [F3]Shares are held in a family trust of which the Reporting Person is a co-trustee with his wife.
Documents
Issuer
Sorrento Therapeutics, Inc.
CIK 0000850261
Entity typeother
Related Parties
1- filerCIK 0001638744
Filing Metadata
- Form type
- 4
- Filed
- Sep 14, 8:00 PM ET
- Accepted
- Sep 15, 9:26 PM ET
- Size
- 8.1 KB